CHLOROPHYLLIPT ARTERIUM

INSTRUCTION FOR MEDICAL USE OF THE MEDICINAL PRODUCT CHLOROPHYLLIPT Arterium (CHLOROPHYLLIPT Arterium)

Composition:

Active ingredient: 1 ml of solution contains Extract of eucalyptus leaves, dry (extractum ex folii eucalypti spissum), calculated as 100% content of dry substance (1:15.3) – 10 mg;

Excipient: ethanol 96%.

Pharmaceutical form. Alcohol solution.

Main physicochemical properties: dark green liquid. Formation of sediment during storage is permissible.

Pharmacotherapeutic group. Antiseptics and disinfectants.

ATC code D08AX.

Pharmacological properties.

Pharmacodynamics.

The drug has antibacterial activity against staphylococci, including antibiotic-resistant strains.

Pharmacokinetics.

Not studied.

Clinical characteristics.

Indications. Treatment of infections caused by antibiotic-resistant staphylococcal strains, burn disease, trophic and slowly healing limb ulcers, as part of combined therapy for postoperative, postpartum, and other septic conditions of different origin, treatment of intestinal staphylococcal dysbiosis and eradication of staphylococcal carriers, cervical erosion.

Contraindications. Hypersensitivity to chlorophyllipt or to any other component of the drug.

Interaction with other medicinal products and other forms of interaction. It should be noted that if hydrogen peroxide residues are present in the wound, Chlorophyllipt Arterium precipitates. Therefore, after wound irrigation with hydrogen peroxide, its residues should be removed using sterile 0.9% sodium chloride solution. Enhances the effect of antiseptic agents.

Special precautions for use.

Use during pregnancy or breastfeeding. The efficacy and safety of the drug during pregnancy or breastfeeding have not been studied; therefore, the drug should not be used in these patient groups.

Ability to affect reaction speed when driving or operating machinery. Since the drug contains 96% ethanol, caution should be exercised when driving or operating machinery.

Method of Administration and Dosage

For adults and children aged 12 years and older, the drug is administered orally, topically, and as enemas. For children aged 12 years and older, the drug should be used only as prescribed by a physician.

Oral administration of Chlorophyllipt Arterium is indicated for intestinal carriage of staphylococci and for prevention of postoperative complications. Adults and children aged 12 years and older should take 5 ml of the 1 % alcoholic solution diluted in 30 ml of water, three times daily, 40 minutes before meals, on a daily basis. The duration of treatment is determined individually, depending on the therapeutic efficacy and severity of the disease.

For the treatment of intestinal staphylococcal carriage, Chlorophyllipt Arterium may also be administered as an enema (20 ml of the 1 % alcoholic solution diluted in 1 liter of water – this is the dose for one enema). The procedure should be performed once daily. The enema should be administered every other day. The treatment course consists of 10 procedures.

For topical use (treatment of burns and trophic ulcers), dilute the 1 % alcoholic solution with 0.25 % novocaine solution in a 1:5 ratio.

For the treatment of cervical erosion, first dry all folds of the vaginal mucosa and the vaginal portion of the cervix with a tampon, then apply the 1 % solution of Chlorophyllipt Arterium to the cervical canal. For vaginal douching, dilute 15 ml of the 1 % alcoholic solution in 1 liter of water.

The duration of the treatment course depends on the course of the disease and is determined individually by the physician.

Children. The drug may be administered to children aged 12 years and older only as prescribed by a physician.

Overdose. An overdose may lead to an intensification of adverse reactions. Treatment is symptomatic.

Side effects.

Immune system side effects: allergic reactions are possible during the use of the medication, including mucosal swelling, hyperemia, itching, and rash.

Shelf life. 2 years.

Storage conditions. In the original packaging at a temperature not exceeding 25 ºC.
Keep out of reach of children.

Packaging.

100 ml in a glass or polymer bottle, 1 bottle per carton;
100 ml in a jar, 1 jar per carton.

Prescription status. Prescription only.

Manufacturer.

JSC "Halychpharm".

Manufacturer's address and place of business.

6/8 Opryshkivska Street, Lviv, 79024, Ukraine.